Know Cancer

or
forgot password

A Prospective Study of Quality of Life in Patients With Bladder Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Bladder Cancer

Thank you

Trial Information

A Prospective Study of Quality of Life in Patients With Bladder Cancer


Inclusion Criteria:



- All patients (male and female) who are diagnosed with bladder cancer

- Patients must be scheduled for radical cystectomy and urinary diversion are and/or
being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy.

- Participants must be able to speak English.

- Participants must be able to provide informed consent.

- Participants must be 18 years of age or older to enroll.

- Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy.

- Participant may have had intravesicle chemotherapy or immunotherapy (BCG,
Interferon).

Exclusion Criteria:

- Subjects may be excluded from the study based on the following criteria:

- Follow-up care not obtained at MSKCC.

- Metastatic disease at diagnosis.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Prospectively characterize the impact of radical cystectomy and different urinary diversions on quality of life of bladder cancer patients.

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

Bernard Bochner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

08-076

NCT ID:

NCT00745355

Start Date:

August 2008

Completion Date:

August 2014

Related Keywords:

  • Bladder Cancer
  • Quality of Life
  • Questionnaires
  • 08-076
  • Urinary Bladder Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer Center New York, New York  10021